Morris Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$3.58M Sell
11,086
-124
-1% -$39.3K 3.38% 7
2022
Q2
$3.63M Sell
11,210
-11,845
-51% -$3.56M 3.24% 8
2022
Q1
$6.6M Sell
23,055
-605
-3% -$156K 5.12% 4
2021
Q4
$6.54M Sell
23,660
-350
-1% -$88.7K 4.8% 5
2021
Q3
$5.55M Sell
24,010
-846
-3% -$209K 4.37% 4
2021
Q2
$5.71M Sell
24,856
-412
-2% -$82.8K 4.31% 4
2021
Q1
$4.72M Sell
25,268
-645
-2% -$126K 3.83% 4
2020
Q4
$4.38M Sell
25,913
-1,478
-5% -$221K 3.59% 6
2020
Q3
$4.05M Sell
27,391
-1,735
-6% -$269K 3.58% 7
2020
Q2
$4.78M Sell
29,126
-1,734
-6% -$266K 4.32% 5
2020
Q1
$4.28M Sell
30,860
-909
-3% -$125K 4.58% 5
2019
Q4
$4.17M Sell
31,769
-596
-2% -$69.1K 3.49% 8
2019
Q3
$3.62M Sell
32,365
-5,137
-14% -$572K 3.18% 9
2019
Q2
$4.16M Sell
37,502
-4,216
-10% -$496K 3.46% 8
2019
Q1
$5.41M Sell
41,718
-1,986
-5% -$241K 4.24% 6
2018
Q4
$5.06M Sell
43,704
-1,239
-3% -$138K 4.31% 5
2018
Q3
$4.82M Sell
44,943
-470
-1% -$47K 3.22% 9
2018
Q2
$3.88M Buy
+45,413
New +$3.73M 2.72% 16

Other funds holding LLY

Morris Capital Advisors's LLY Position: Q3 2022 in Review

Morris Capital Advisors reduced its Eli Lilly (LLY) stake by 1.1% in Q3 2022, selling an estimated $39.3K and leaving 11,086 shares worth $3.58M. The position accounts for 3.38% of the portfolio, ranked #7.

Morris Capital Advisors first reported a position in LLY in Q2 2018 and has held it in 18 quarters since. The position peaked at $6.6M in Q1 2022. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • Morris Capital Advisors held 11,086 shares of Eli Lilly worth $3.58M as of Q3 2022.
  • Morris Capital Advisors sold 124 Eli Lilly shares in Q3 2022, an estimated $39.3K.
  • Eli Lilly made up 3.38% of Morris Capital Advisors's portfolio in Q3 2022, its #7 holding.
  • Morris Capital Advisors first reported a position in Eli Lilly in Q2 2018 and has held it in 18 quarters since.
  • Morris Capital Advisors's Eli Lilly position peaked at $6.6M in Q1 2022.
  • 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on Morris Capital Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.